Transcript Highlights:

• Thanks for taking the time out of your schedule for joining us. All right.
• Thanks for taking the time out of your schedule for joining us. Thank you. You're welcome.
• If there was a prior investigation by CPS and there was an allegation that drugs could harm the child
• some drug portion to them, and so this is the one basic thing we can do to start.
• Drug portion to them.

Summary: The Senate Human Services Committee first held a public hearing on the gubernatorial appointment of Angela Ramirez to serve as Secretary of the Department of Social and Health Services. Ramirez described her background in public service and said her priorities would include improving technology, addressing workforce shortages, strengthening relationships with labor, tribes, and community organizations, and protecting DSHS programs and clients during uncertain budget and federal conditions. Lieutenant Governor Denny Heck also spoke in support of her confirmation, and members raised questions about needed improvements at DSHS. The committee then moved into executive session on six bills. On SB 6062, dealing with juvenile rehabilitation, midpoint reviews, bed capacity, and transfers between DCYF and DOC facilities, all six proposed Christian amendments failed and the committee advanced the Wilson substitute to Ways and Means. On SB 6308, concerning shelter care conditions for children under five in dependency cases, the committee rejected four Christian amendments and adopted a Wilson amendment clarifying that the bill does not supersede the Washington Indian Child Welfare Act; the bill then advanced to Ways and Means. On SB 6319, addressing community-based referrals for high-risk families with children under four and parental opioid use, the committee rejected three Christian amendments and adopted a technical Wilson amendment; the substitute then advanced to Ways and Means. The committee also considered SB 6286, which would authorize Department of Health inspections of private detention facilities and create a repair account funded by fines for inspection violations. All Christian amendments and one Warnick amendment failed, and the proposed substitute was advanced to Ways and Means. On SB 6080, regarding contracts and conditions for jails holding people in federal custody, all Christian amendments failed and the substitute was advanced to Rules. Finally, on SB 6184, an agency-request bill making technical and program updates, the committee adopted the bill with one amendment and sent it forward subject to signatures. The committee recessed partway through the agenda, returned to vote on the first six bills, and announced that remaining bills and the gubernatorial appointment would be taken up the next day.

Transcript Highlights:

• I strongly oppose HB 2415 in making the kratom alkaloid 7-OH a Schedule I drug.
• I strongly oppose HB 2415 in making the kratom alkaloid 7-OH a Schedule I drug.
• Making 7-OH Schedule I will leave consumers with three options: suffering, street drugs, or suicide.
• I think to be able to regulate and in some way control these types of drugs is important.
• I think to be able to regulate and in some way control these types of drugs is important.

Summary: The Senate Judiciary and Elections Committee approved the minutes from its March 18, 2026 meeting and then took up a long agenda of bills and a clemency nomination. HB 2825, as amended, was heard first. The bill would replace criminal enforcement tools for nonpayment of fines, fees, restitution, and surcharges with a civil collection process, including a required summons and civil default procedures. Supporters said it would streamline restitution collection and reduce costs, while opponents argued it would weaken victims’ rights and remove effective enforcement leverage. The committee adopted the Rogers amendment and passed the bill 5-2. The committee also confirmed Neil McDowell to the Arizona Board of Executive Clemency by a 6-0 vote after hearing his background in corrections and his plans to help the board function efficiently. The committee then passed HB 4070, as amended, 5-2. That bill bars incorporation of corporations whose officers, directors, or trustees have been convicted of sex trafficking or human trafficking, and expands civil liability to those who facilitate trafficking. Supporters framed it as a corporate accountability tool to deter trafficking, while the ACLU opposed it as overbroad and potentially sweeping in people not intended to be covered. HB 2720, which increases penalties for paying or agreeing to pay for sexual conduct and adds a fee to support anti-trafficking services, also passed, 4-3. Supporters, including survivors and law enforcement, said it targets demand and helps victims; opponents warned it could criminalize victims and lacked sufficient safeguards. The committee heard several additional bills. HB 2047 would raise trespass penalties after eviction-related writs of restitution from third-degree to first-degree trespass; the sponsor and constables said it would improve scene safety and encourage law enforcement response. HB 2136 would create new crimes for “civil terrorism” and “subversion” and increase penalties for certain highway obstruction; the ACLU argued it would punish protest and speech critical of government. HB 2406 would make images and recordings of abused children and deceased minors confidential, limit dissemination, and impose civil and criminal penalties for misuse; supporters said it would prevent re-victimization and reduce trauma, while defense and media concerns were raised about access. HB 2415, dealing with kratom and 7-OH products, drew sharply divided testimony over whether the bill is a needed safety regulation or an overbroad ban that could push users to illicit drugs; the transcript ends before a final vote on that bill.

Transcript Highlights:

• dates of, I'm gonna ask if we can do like LFC and LESC since we have an extra 5 days, if we can schedule
• Um, like I said, we, we're trying to stay right on, on schedule.
• , um, on a donation basis, and also to distribute those drugs.
• Facilities might not have the particular budget or inventory to provide those kinds of drugs.
• We, we are ahead of schedule. Don't get used to it. It's, uh, it's not how it happens.

Transcript Highlights:

• So House Bill 249 will be scheduled at a later date.
• According to the Medicaid fee schedule, the effective date was January 1, 2015.
• We have no influence or ability to influence. ...fee schedule, which is set by the feds.
• In our FIR, it says that they are reimbursed at 100% of the Medicare fee schedule.
• Actually, Representative, we are paying 150% of the Medicare fee schedule.

Keywords: 996, all

Transcript Highlights:

• <00:09:54.760><c> 2026</c> scheduled 2026 scheduled 2026 expiration<00:09:57.399><c> for</c><00:09:57.640
• So the Medical Assistance covers weight loss drugs, and it has for several years.
• drugs within that class.
• </c><00:41:41.000><c> has</c> time the list of approved drugs has time the list of approved drugs has
• </c><00:41:54.920><c> through</c> patients accessing those drugs through patients accessing those drugs

Keywords: 919, house, all

Summary: Minnesota Management and Budget presented the February 2025 budget and economic forecast, with Commissioner Aon Campbell, State Economist Anthony Becker, and Budget Director Anam Mingi outlining updated revenue, spending, and long-term balance projections. The state’s FY 2026-27 general fund outlook remains positive but weaker than in November, with an ending balance of $456 million, down $160 million from the prior forecast. Looking ahead, the planning years FY 2028-29 show a projected deficit of just under $6 billion, driven largely by spending growth outpacing revenues. Officials emphasized that discretionary inflation is a major factor in the forecast, but also noted that those amounts are not automatically appropriated and would require legislative action. Becker said the national outlook has changed since November, with higher expected inflation, higher interest rates for longer, and slower growth in later years. He highlighted uncertainty around tariffs, trade policy, immigration policy, federal spending, and possible changes to tax and debt-ceiling policy, all of which could affect Minnesota’s economy and revenues. Minnesota’s labor market remains tight, with low unemployment and rising wages, and the revenue forecast was revised upward overall for FY 2026-27, including higher income and sales tax receipts, though corporate tax revenue was slightly lower than previously projected. Mingi said projected general fund spending is up $79 million in FY 2026-27 and $960 million in FY 2028-29 compared with November. The largest increases are in education and health and human services, especially due to inflation, higher pupil counts, special education costs, long-term care, and higher Medical Assistance spending. She noted that higher utilization of weight-loss drugs also raises Medicaid costs, and that a smaller assumed bonding bill helps offset some debt service costs. The commissioner and staff repeatedly warned that federal policy changes, especially possible Medicaid reductions, pose a major risk; they said Minnesota could face billions in lost federal funding, including a potential $2.4 billion hit if the enhanced Medicaid match for adults without children were eliminated. No votes or legislative actions were taken in the presentation.

Transcript Highlights:

• of these drugs added to the preferred drug list.
• for each drug.
• for each drug.
• And in 2025, drugs.
• </c> drugs made up 8.3% in 2025. drugs made up 8.3% in 2025.

Keywords: 958, all

Summary: The Medicaid Oversight and Advisory Board met on February 23, 2026, approved the January 12 minutes, and then focused primarily on Kentucky Medicaid’s coverage and potential expansion of GLP-1 drugs, especially for weight loss. Department for Medicaid Services Commissioner Lisa Lee explained that Medicaid currently does not cover drugs for weight loss, anorexia, or weight gain, but the department had filed a regulation to remove that blanket exclusion so GLP-1s could be covered when used for an underlying health condition. She said the administrative regulation review subcommittee found the regulation deficient, and the co-chairs wanted the board to discuss the policy and financing implications before any change. DMS also said it would be open to adding caveats to ensure coverage would not extend to cosmetic weight loss alone. The department provided several data points on current utilization and spending. In 2025, Kentucky Medicaid paid for appetite-stimulating drugs such as Megestrol, Dronabinol, and Marinol, but did not pay for weight-loss drugs. For GLP-1s, DMS said coverage began in 2025 and is limited to FDA-approved medical conditions, with prior authorization requiring a type 2 diabetes diagnosis code and A1C documentation. DMS reported $234.6 million in GLP-1 spending in 2025 before rebates, about 240,931 prescriptions, and said GLP-1s accounted for 7.3% of pharmacy spend in 2024 and 8.3% in 2025. It also said there were 24,844 expansion members and 13,638 non-expansion members using GLP-1s, with spending of about $156 million and $78.5 million respectively, and that 10 pediatric weight-loss prescriptions were covered under EPSDT. The department said outcome analyses, including whether GLP-1 use reduces insulin or other diabetes treatment, are underway and should be completed in a couple of months. Members asked about cost, rebates, and whether the state should wait for more outcomes data before expanding coverage. DMS said average reimbursement to pharmacies was $975 per prescription and the average dispensing fee was $109; it also said 2025 rebate invoices totaled $90.8 million, with $7.6 million collected so far. Several members expressed concern about the high cost and the need to evaluate whether the drugs improve health outcomes before expanding access, while others noted the potential benefits for obesity and diabetes treatment. Some members also discussed whether GLP-1s are effectively being used for weight loss in diabetic patients and whether broader data collection should be used to assess long-term value. After the Medicaid discussion, Eli Lilly executive Tracy Sims presented on obesity as a chronic disease and the economic burden it creates in Kentucky. She said Kentucky’s adult obesity rate is a little over 37%, that obesity is linked to about 200 diseases, and that untreated obesity costs the state billions in GDP and hundreds of millions in state budget impact. She highlighted recent federal access programs for GLP-1s, including a Medicaid-related program that she said could lower the state share of a Zepbound prescription to about $71 per month after federal matching. No votes were taken on the GLP-1 policy question during the meeting, and the main action was the receipt of testimony and discussion of the department’s proposed regulatory change.

Transcript Highlights:

• </c><00:31:29.840><c> and</c><00:31:30.000><c> actually</c> the actual drug and actually the actual drug
• </c> drug helpful, but a lot of them will. drug helpful, but a lot of them will. and<00:40:14.560><c>
• </c> the power to pass laws that compel drug the power to pass laws that compel drug makers<02:17:36.080
• </c><02:18:05.679><c> companies</c> power to see that the drug companies power to see that the drug companies
• </c> level drug offense. level drug offense.

Keywords: 1183, house

Transcript Highlights:

• The court may schedule progress or review hearings to evaluate.
• Again, under current law, the court may but is not required to schedule these hearings.
• There's a program for that, the drug offender sentencing alternative.
• And drug offenses are made eligible. Right. Okay. Terrific. Well, thanks.
• Drug enforcement and other things that really help the community, but tactics have changed.

Bills: HB2217, HB2558, HB2641, HB2648, HB1239, HB1591, HB2209, HB2310, HB2526

Keywords: rehabilitation, felony offenses, criminal justice reform, first-time offenders, pathways to rehabilitation, mental health, sentencing alternative, criminal justice, diversion programs, HB 2641, ICE out act, law enforcement hiring, immigration and customs enforcement, ICE officers, former federal employees, sworn officer, police staffing, general authority law enforcement agency, limited authority law enforcement agency, immigration enforcement

Transcript Highlights:

• So it's kind of our schedule. Right now we're getting ready to start the right-of-way phase.
• Construction of this project is scheduled to be completed in the summer of 2028.
• The scheduled completion date of this project, once open, is fall or winter of 2028.
• Construction of this project is scheduled to be completed the summer of 2028.
• The scheduled completion date of this project once open is fall winter of 2028.

Summary: The Senate Transportation Committee met for work sessions, public hearings, and executive action. In the work session, WSDOT briefed the committee on the U.S. 12 corridor near Walla Walla and the North Spokane Corridor. Brian White said U.S. 12 is an eight-phase project with seven phases complete, and phase eight would finish the corridor, improve freight mobility and safety, and include a jurisdictional transfer of the old highway back to Walla Walla County. He said the project remains short of full funding, including a gap between the $350 million corridor cost and the $110 million federal Rural Surface Transportation grant, but WSDOT hopes to build smaller independent-utility pieces and begin construction in summer 2027. Charlene K. then reported that the North Spokane Corridor is seven of eight highway miles open, with major remaining work on the I-90 connection and related interchanges, bridges, and trail segments. She described the project as on track for design completion in 2027 and construction completion around 2030, while noting risks tied to federal approval, tight construction space, labor and contractor availability, utilities, and community impacts. The committee also heard from Karen Messmer of the Cooper Jones Active Transportation Safety Council, who summarized the council’s 2025 report and 2026 priorities. She emphasized that pedestrian and bicyclist fatalities remain unacceptably high and urged a safe-system approach focused on safer speeds, roads, road users, vehicles, land use, and post-crash care. She highlighted recommendations including safety-based performance measures, better speed management, more local safety planning support, improved driver education, attention to micromobility and large vehicles, and faster toxicology and crash-data processing. In public hearings, the committee heard Senate Bill 6131, which would expand the Washington Traffic Safety Commission’s fatal crash review authority, designate it as a public health authority for limited access to health information, and create a confidential fatality review committee. The sponsor and Traffic Safety Commission said the bill would help identify common contributing factors in all fatal crashes while protecting confidential information; a media representative testified that the bill preserves public access to records already open and supports the goal of improving safety. The committee also heard Senate Bill 6155, which would extend disability parking placard renewal from every five years to every 20 years and remove the need for a health care practitioner’s signature at renewal; supporters said this would reduce burdens on permanently disabled people, while opponents warned it could increase fraud and misuse of placards. Finally, the committee heard Senate Bill 6238, which would raise the minimum tug escort horsepower for oil tankers in restricted waters to 3,000 horsepower or 5% of tanker deadweight, whichever is greater; the sponsor and Board of Pilotage said the change would align statute with current practice and newly adopted rules. Testimony was mixed, and the hearing closed with two people signed in pro and two con. In executive session, the committee advanced several bills. It passed Senate Bill 5746 on EV charging infrastructure property crime, Senate Bill 5824 on fifth wheel travel trailer length, Senate Bill 6110 on e-bikes and e-motos, Senate Bill 5839 on county ferry district passenger-only service, and Senate Bill 6148 on regional transit authority bond terms, all with due pass recommendations to the Rules Committee. An amendment to SB 6110 adding several state agency leaders to the e-moto work group was rejected. The committee adjourned after signing committee reports.

Transcript Highlights:

• He said the second part of the bill includes Schedule I drugs.
• He said the FDA drug approval process is so expensive that a drug that could help only 20,000 people
• is to prevent the direct and indirect cost to the state of millions of dollars caused by alcohol, drug
• It's through things like training for alcohol and tobacco retailers to prevent sales to minors, drug
• Prevent sales to minors, drug take-back events to collect unused medication, vape drop boxes in middle

Keywords: 959, house, all

Transcript Highlights:

• “When is the last time your office updated the schedules?”
• You said you just updated the schedules recently?” “Yes.”
• “All right, those schedules are in place now?”
• to become the new schedule; that is correct?”
• Robinson, don't we have limitations with opioid drugs now?

Summary: The committee first voluntarily deferred House Bills 460 and 561, then took up House Bill 1101 on workers’ compensation. The sponsor said the bill would define maximum medical improvement, adjust fraud provisions, shorten temporary total disability and supplemental earnings benefit periods, and revise vocational rehabilitation rules; an amendment removed proposed age-based termination language for benefits. Business groups including LABI supported the bill as a way to reduce Louisiana’s comparatively high indemnity costs and align the state with regional norms, while injured-worker advocates and attorneys strongly opposed it, arguing it would cut benefits, shift medical and disability decisions away from treating physicians and judges, broaden fraud too far, and potentially push costs onto public programs. After debate, the committee voted to report HB 1101 with amendments. House Bill 282 was voluntarily deferred. House Bill 293, which would add sexual orientation and gender identity to Louisiana employment discrimination protections, drew generally supportive testimony from the sponsor and supporters, with some members raising questions about religious exemptions and federal law. The committee ultimately voted against reporting HB 293 favorably. House Bill 390, providing unpaid leave protections for domestic abuse survivors at larger employers, was presented as a tool for survivors, but the committee split 6-6 on a motion to report it favorably; the tie resulted in the bill being voluntarily deferred. The committee then heard House Bill 456, which would expand workers’ compensation petition requirements and allow employers or payers broader access to file disputed claims and seek discovery. Supporters argued employers currently lack a practical way to obtain records and challenge claims without first cutting off benefits, while opponents said the bill would revive a rejected 2012 approach, increase litigation, and undermine the no-fault workers’ compensation bargain. The discussion centered on whether the bill would preserve benefits while allowing discovery or instead encourage more disputes and penalties. The transcript ends with testimony still underway on HB 456, with no final vote shown.

Transcript Highlights:

• Then you'll see items 17 through 22 are new-to-market drugs that we are leaving not covered.
• Then you'll see items 17 through 22 are new-to-market drugs that we are leaving not covered until we
• we're just doing some maintenance work to prefer the generic medication in these particular diabetes drugs
• Drugs. Any questions on April? Members, any questions?
• You've done your due diligence and and quit paying on a lot of drugs.

Summary: The State Insurance Programs Oversight Subcommittee met on June 17 and reviewed a series of Employee Benefits Division and Office of Property Risk items. Grant Wallace presented March and April formulary changes, explaining that the updates favored lower-cost generics, re-tiered some drugs, left several new-to-market drugs uncovered pending more evidence, and added quantity limits in some cases. The committee approved those formulary recommendations. The subcommittee also approved a cell and gene therapy policy that would exclude automatic coverage of those therapies and route them through prior authorization and review, with members noting the process should not delay urgent cases and that appeals remain available. Members then discussed a UAMS professional consultant services contract amendment for pharmacy benefit consulting. The discussion focused on confusion over the dollar amount and scope, with Wallace clarifying that the committee was being asked to approve up to $2.596 million, including optional services related to coupon and rebate management that could be used later without returning for another approval. Several members raised concerns about matching the written contract to the approval amount and about the relationship to the current pharmacy benefit manager, but the committee ultimately approved the item with the understanding that any use of the optional services would return to the committee. The committee also reviewed, without objection, a Blue Cross/Blue Advantage third-party administrator contract, a CompSack employee assistance program contract, and approved proposed 2027 employee and public school health plan rates of 9.8% and 4.9% increases, respectively. Wallace also said the UnitedHealthcare rebid was in final negotiation and would return in August. On the property risk side, the committee reviewed permanent rules for the property insurance program, a contingency-fee subrogation contract with Denenberg-Tuffly, and extensions for Sedgwick Claims Management, Actuarial Advantage, and Stevens Capital Management. Members asked about claim-adjustment delays after a major winter storm, and Wallace said performance guarantees and communication requirements had been added, with claims still expected to vary by case. The committee also approved 2026-27 captive insurance program rates, which included no change to minimum deductibles, lower rates for K-12 and higher education, a higher rate for state agencies, and an overall 10% reduction. Wallace said the reductions reflected improved actuarial foundations, better claims management, and the program’s first-year performance. The meeting adjourned after approving the rate item.

Transcript Highlights:

• The other one is the tax on drugs, prescription drug warehousing and reselling.
• It's going to..." "...increase the cost of prescription drugs on people, on hospitals, on insurers.
• We gave them a choice of funding infants, a program for infants who were born drug to drug-addicted mothers
• And in lieu of doing that, they chose to fund a program that gives drug paraphernalia to drug addicts
• So it's a Fund a program that gives drug paraphernalia to drug addicts.

Summary: Senate and House Republican leaders used the weekly media availability to criticize the Democratic majority’s budget and tax proposals, framing the session around affordability and fiscal restraint. They said the operating budgets rely on unsustainable one-time money, rainy day funds, and an income tax proposal they argued is unconstitutional and likely to drive businesses and wealthy residents out of Washington. They also said House and Senate Republicans offered budget amendments aimed at property tax relief, restoring money to public works, and reducing reliance on new taxes, but those efforts were rejected. The lawmakers also highlighted several bills they said failed to advance, including juvenile rehabilitation reforms, child endangerment/child fatality reporting measures, and tort reform. Braun said he plans to raise those issues, along with the income tax and budget concerns, in a meeting with the governor, and asked whether the governor would veto the income tax if his conditions are not met. Connors and Abbarno added that Republicans are still working with some Democrats, including on a constitutional amendment approach to any income tax, but said the majority is moving too quickly and without adequate safeguards. Other topics included the U.S. Supreme Court ruling on California transgender policies, which Republicans described as a win for parents’ rights and potentially relevant to Washington school policy, and a House bill affecting data centers, which they opposed as harmful to jobs, energy innovation, and local tax bases. They also criticized additional taxes under consideration, such as nicotine, prescription drug, bag, bottle, and data-center-related taxes, arguing these would worsen affordability. The session ended with Republicans saying they had little influence in the budget conference process and vowing to keep fighting the income tax and other tax increases through the final days of the session.

Transcript Highlights:

• FDA and scheduled or rescheduled by the USDA to the identical schedule under the Controlled Substances
• FDA and scheduled or rescheduled by the USDA to any schedule other than Schedule I under the Controlled
• FDA that was scheduled or rescheduled.
• So what they're telling us, FDA that was scheduled or rescheduled.
• It has a specific schedule. It's under FDA, but DEA, right?

Summary: The committee heard a long list of Senate bills, mostly on consent, covering appropriations, public records, workers’ compensation, state hiring, burial costs, military flags in HOAs, court-ordered treatment, mental health service of process, medical examiner authority, tribal MOUs for DCS, controlled substances scheduling, EMT privacy, mammography notices, assisted living referral disclosures, accommodation school GED eligibility, released-time religious instruction, school board and charter governance issues, firearm safety instruction, student eligibility for extracurriculars after criminal convictions, Celebrate Freedom Week, tax-credit scholarship administration, CPA and insurance licensing pathways, immigration-related arrest notifications, defamation standards, peace officer certification for veterans, mandatory child abuse reporting, attorney licensing, business emergency-call penalties, unlawful occupant removals, attorney discipline costs, fentanyl sentencing thresholds, concealed weapons on campuses, firearm muffling devices, utility-worker assault penalties, water planning, environmental review for power plants and SMRs, groundwater recovery, voter registration rules, campaign address privacy, and federal land acquisition notifications. Several bills were pulled from consent for further discussion, including SB 1078, SB 1435, SB 1567, SB 1665, SB 1184, SB 1586, SB 1741, SB 1424, SB 1475, SB 1572, SB 1142, SB 1055, SB 1099, SB 1107, SB 1148, SB 1068, and SB 1069. Members raised concerns about constitutional issues, due process, school funding, public safety, and whether some proposals were unnecessary or duplicative. Supportive comments were also made on a few measures, such as expanded pathways for students in accommodation schools, child welfare coordination with tribes, and alternative certification or licensing pathways. The discussion included notable debate on SB 1166, which would allow some 11th graders and students over 16 in accommodation schools to receive GED preparation; members split between concerns about encouraging students to leave high school early and support for youth in detention, emancipation, or unstable situations. SB 1127 on mandatory reporting was clarified to require direct reporting of known abuse or neglect to DCS rather than delegation to another person. SB 1188 on controlled substances drew questions about how federal rescheduling would be mirrored in state law. The meeting ended with announcements and an “Affordability Award” recognizing Rep. Stahl Hamilton, followed by a request for guests to leave for a closed caucus.

Transcript Highlights:

• Ladies and gentlemen, we have 49 minutes left in the scheduled committee time.
• . of each vaccine on the CDC's child and adolescent immunization schedule.
• Yeah, I think you're not answering my question about other drugs, but we can get back to that.
• So what I'm asking, what I'm getting at is why this particular drug was chosen for this bill and this
• And from my professional experience, I only know of this drug to treat parasites.

Summary: The committee first took up CS for SB 896 on school safety, which would expand the Guardian program to public postsecondary institutions, require active assailant response plans and threat management protocols, improve reporting and information sharing, and make it a felony to discharge a weapon within 1,000 feet of a campus. A late-file amendment by Senator Polsky was adopted to clarify that students who are also employees or faculty at a public postsecondary institution are not eligible for the Guardian program. The bill drew strong opposition from faculty, students, and gun-safety advocates who argued that more guns on campus would create confusion, weaken safety, and undermine campus police; supporters said trained guardians would improve deterrence and protection. After debate, the committee reported the bill favorably by a roll call vote. The committee then considered SB 1690 on child care and early learning services, which updates child care laws, reduces some regulatory burdens, and expands the Florida Education Foundation’s authority to fundraise for early learning from birth through VPK. Members discussed oversight of the related direct-support organization and the removal of certain notice requirements, while supporters from Moms Rising and other advocates said the bill would help families access affordable, high-quality child care and support home-based providers. One opponent argued the bill added more government regulation, but the committee adopted the amendment and reported the bill favorably. Next, the committee passed CS for SB 118, a narrow bill on non-ad valorem special assessments for recreational vehicle parks, clarifying how assessments are calculated for RV spaces and campsites. The bill received supportive comments from RV advocates and was reported favorably without controversy. The committee then took up CS for SB 1220, the Department of Transportation package, which included provisions on seaports and airports, personal delivery devices, autonomous vehicles, broadband and utility permitting, and advanced air mobility. Amendments were adopted that revised research institute membership, limited some delivery-device provisions, and clarified cruiser light rules for law enforcement; after questions about utility preemption and PDD safety, the bill was reported favorably. Finally, the committee began hearing SB 1756 on medical freedom, which would require new vaccine educational materials, expand school-entry exemptions to include conscience-based objections, limit the Surgeon General’s emergency vaccination authority, and allow behind-the-counter ivermectin for adults with written information and liability protections. The bill drew extensive testimony from both supporters and opponents, with supporters emphasizing parental rights, informed consent, and vaccine injury concerns, and opponents warning about reduced immunization rates, public health risks, and the appropriateness of ivermectin provisions. The transcript ends during public testimony and debate on SB 1756, before final action on that bill is shown.

Transcript Highlights:

• And then the last thing, if we're able to get that far on the schedule, would be regular order number
• It's going to be difficult to get through the schedule for today, and it's fine. Rep.
• So all it is, is it gives them a little more time before we implement a fee schedule. Rep.
• The insurance companies and PBMs notify the formulary when they are picking the cheapest drug.
• If you're wanting to schedule them for tomorrow, we need to know. That have not been heard yet.

Bills: HR310, HR314, HR316, HR317, HR321, HR275, HR276, HR279, HR282, HR286, HR289, HR292, HR295, HR302, HR319, HCR112, HR307, SCR59, SCR61, SCR62, SCR68, SCR69, SCR70, SCR54, SCR55, SCR64, SCR75, HCR79, HCR104, HB75, HB410, HB719, HB750, HB944, HB1098, HB1220, HB1252, HB359, HB210, HB468, HB1117, SB382, HB368, HB552, HB732, HB870, HB1236, SB29, SB42, SB43, SB149, SB208, SB274, SB300, SB312, SB387, SB389, SB401, HR74, HB998, HB901, HR20, HCR65, HCR71, HCR98, HB284, HB306, HB341, HB366, HB393, HB458, HB577, HB603, HB605, HB614, HB625, HB646, HB733, HB752, HB773, HB798, HB911, HB955, HB996, HB1035, HB1069, HB1113, HB1140, HB1180, HB1191, HB1240, HB1255, SB82, SB89, SB97, SB123, SB237, HB36, HB42, HB74, HB119, HB159, HB258, HB259, HB302, HB414, HB459, HB848, HB956, HB1017, HB1028, HB1095, SB217, SB283, SB469

Keywords: oil and gas, orphan wells, inactive wells, shut-in wells, marginal wells, plugging and abandonment, well decommissioning, site remediation, site restoration, Oilfield Site Restoration, OSR program, financial security, bonding, taxpayer liability, public liability, offshore wells, onshore wells, coastal erosion, Department of Conservation and Energy, natural resources

Transcript Highlights:

• Um name it, you know, drugs and alcohol.
• ,</c><03:07:53.920><c> drug</c> Amber, silver alerts, um, drug, drug Amber, silver alerts, um, drug,
• </c><03:08:23.680><c> Um,</c> drug trafficking on reservations?
• Um, drug trafficking on reservations?
• ,</c> instead of getting stuck into the drugs, instead of getting stuck into the drugs, the<04:23:41.359

Keywords: 916, all

Transcript Highlights:

• brand-name drug.
• brand-name drug.
• I said, well, it's ...generic drug as a brand-name drug. I said, well, it's generic.
• And they said, well, your drug is now called a generic drug with a brand name that is generic drug.
• Drugs like Advil and Tylenol didn't cut it.

Keywords: 995, all

Summary: The Joint Committee on Health Care Financing held a public hearing on 16 bills, with the chairs noting a busy legislative day and asking speakers to keep testimony brief. The committee first heard testimony on Senate 860/House 1405, the Medicare for All bill, with Sen. Jamie Eldridge and many advocates, clinicians, municipal officials, and patients arguing that a single-payer system would make care a right, reduce administrative waste, lower costs, and protect residents from rising premiums, medical debt, and hospital closures. Several speakers cited the Steward hospital crisis, affordability problems, and polling or ballot questions showing public support for single-payer coverage. No vote was taken during the hearing. The committee then took testimony on S. 863, a bill on non-opioid options for chronic pain. Pain specialists, patients, and advocates said the bill would improve care coordination for MassHealth members, expand access to non-opioid medications, require provider education, and collect data on chronic pain. Testifiers described long delays in diagnosis and treatment, stigma toward pain patients, and the need for multidisciplinary care and transportation support. Again, the committee heard testimony only and took no action. A large portion of the hearing focused on H. 1360/S. 869, which would prevent discrimination against people with disabilities in health care. Disability advocates, clinicians, and patients described being denied or delayed care, pressured into DNR orders, or treated based on assumptions about quality of life rather than medical facts. Speakers referenced COVID-era crisis standards of care, discriminatory metrics, and personal stories involving canceled procedures, inadequate accommodations, and poor treatment in hospitals. Committee members thanked speakers for their testimony and said they would review the bill and its implications, but no vote was announced. The committee also heard testimony on H. 1399, an individual Medicare marketplace option for municipal retirees, where supporters said it would give cities and towns a lower-cost alternative for retiree health benefits through HRAs and individual Medicare plans. The hearing then returned to Medicare for All testimony, with additional supporters repeating arguments about cost, access, municipal budget pressure, and the need for global budgeting and universal coverage. The transcript ends with continued testimony and no recorded committee vote or final action on any bill.

Transcript Highlights:

• in the third degree to include the possession of any Schedule V substance in any amount.
• Schedule all Schedule V, but what does that include? I'd have to reread and go back. No problem.
• </c> concerning promoting a detrimental drug concerning promoting a detrimental drug in<00:02:34.760>
• </c><00:02:37.400><c> five</c> possession of any schedule five possession of any schedule five substance
• </c><00:05:04.199><c> what</c><00:05:04.280><c> does</c> schedule all schedule five but what does schedule

Keywords: 912, senate, all

Summary: The Judiciary Committee heard testimony on several bills covering criminal justice, elections, and wildfire-related settlement funding. HB 103 would raise the age cutoff for life-without-parole eligibility from 18 to 21; supporters included the Public Defender and others, while prosecutors and some others opposed it. HB 11 would allow civil claims against people or businesses profiting from sexual exploitation or sex trafficking; it drew mostly support but was not ready for a vote and was deferred for further questions. HB 132 would expand a state-initiated expungement pilot to include possession of any Schedule V substance; the Public Defender, ACLU, and oversight groups supported it, with one opponent, and committee questions focused on what substances and how many cases would be affected. HB 145 would require the Hawaii Criminal Justice Data Center to transmit expungement orders to the Judiciary to implement Act 159; the Judiciary and Public Defender supported it, and members discussed technical issues involving multiple defendants and multiple charges. HB 369, a campaign finance housekeeping bill on excess cash contributions, and HB 408, which aligns voter registration-by-mail deadlines with current law, both received support and no opposition of note. The committee also heard HB 1175, which creates appropriations and a trust fund for Maui wildfire settlement claims; the Attorney General’s office, Maui County Council, and Tax Foundation supported it, while one senator said he would vote no because of concerns about House leadership. HB 386, which conforms drug possession thresholds for methamphetamine, heroin, morphine, and cocaine, was supported by law enforcement and prosecutors. HB 134 would require electronic filing of nomination papers; the Elections Office supported it but asked that any convenience fee be authorized in statute, while one witness opposed it over security and cost concerns. After testimony and questions, the committee took up decision-making and passed HB 103 with amendments, deferred HB 11, and passed HB 132, HB 145, HB 369, HB 408, HB 1175, HB 386, and HB 134, with HB 134 amended to clarify no additional charge for electronic filing.

Bills: SR44, HCR1027, SJR50, SJR52, SJR53, HB1185, HB1937, HB2035, HB2137, HB2166, HB3148, HB3323, HB3466, HB3498, HB3661, HB3678, HB3710, HB3977, HB3986, HB4104, HB4108, HB4142, HB4191, HB4274, HB4275, HB4322, HB4336, HB4484, HB3880, HB1687, HB3673, HB1170, HB2959, HB3718, HB3021, HB3443, HB3501, HB4143, HB4326, HB2992, HB3660, SB171, SB1325, SB1980, SB2045, HB4422, HB4423

Keywords: SR44, Senate Resolution 44, Teacher Appreciation Week, teachers, educators, Oklahoma educators, public schools, K-12 education, pre-K, school recognition, education resolution, appreciation week, National PTA, Eleanor Roosevelt, teacher recognition, school staff, classroom, Oklahoma Legislature, concurrent resolution, sine die adjournment